In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Northstar Neuroscience completes $113.9mm IPO

Executive Summary

Northstar Neuroscience (developing an implantable stimulation system to help patients recover from stroke) has sold 8.17mm common shares (including the overallotment) at $15 apiece, netting $113.9mm. The company had initially anticipated a smaller offering of 6mm shares at $12-14, which would have brought in only $78mm.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register